AI assistant
ENTROPY NEURODYNAMICS LIMITED — AGM Information 2020
Oct 5, 2020
64855_rns_2020-10-05_cd5272d5-1938-4966-999b-3c2d1f9029b0.pdf
AGM Information
Open in viewerOpens in your device viewer
==> picture [594 x 78] intentionally omitted <==
ASX ANNOUNCEMENT
6 October 2020
DATE OF ANNUAL GENERAL MEETING AND CLOSING DATE FOR DIRECTOR NOMINATIONS
Exopharm Limited (ASX: EX1) hereby provides notice that the Annual General Meeting (AGM) of the Company will be held on Monday 30[th] November 2020.
Further details relating to the AGM will be advised in the Notice of Meeting which will be available to all shareholders and lodged with the ASX in the coming weeks.
An item of business at the Annual General Meeting will be an election of directors. In accordance with clause 6.2(f) of the Company’s Constitution, the closing date for the receipt of nominations is 9[th] October 2020. Any nominations must be received no later than 5.00pm (AEDT) on Friday, 9[th] October 2020.
This announcement has been authorised for release by the Board of Exopharm Limited.
For more information, please contact:
Sinead Teague Company Secretary Email: [email protected]
EXOPHARM LIMITED ACN: 163 765 991 ASX:EX1 Address: Level 17, 31 Queen Street Melbourne 3000 Telephone: 03 9111 0026 Email: [email protected] Web: www.exopharm.com